![Eric S. Furfine](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric S. Furfine
Direktor/Vorstandsmitglied bei
INGENIA THERAPEUTICS INC.
Profil
Eric S.
Furfine currently works at Ingenia Therapeutics Inc., as Director and Mosaic Biosciences, Inc., as Chief Scientific Officer from 2025.
Dr. Furfine also formerly worked at GlaxoSmithKline LLC, as Director-Biochemical Analytical Pharmacology, Regeneron Pharmaceuticals, Inc., as Vice President-PreClinical Development, ImmuneXcite, Inc., as Chief Executive & Scientific Officer in 2016, Adnexus, as SVP-Research & Preclinical Development, and Sesen Bio, Inc., as Chief Scientific Officer from 2014 to 2016.
Dr. Furfine received his undergraduate degree from Washington University in St. Louis and doctorate degree from Brandeis University.
Aktive Positionen von Eric S. Furfine
| Unternehmen | Position | Beginn |
|---|---|---|
| INGENIA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | - |
Mosaic Biosciences, Inc.
 Mosaic Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial research and development services | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Eric S. Furfine
| Unternehmen | Position | Ende |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 05.02.2016 |
ImmuneXcite, Inc.
 ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which develops monoclonal antibodies for cancer | Vorstandsvorsitzender | - |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Eric S. Furfine
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mosaic Biosciences, Inc.
Mosaic Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial research and development services | Commercial Services |
ImmuneXcite, Inc.
ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which develops monoclonal antibodies for cancer | Health Technology |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Ingenia Therapeutics Inc.
 Ingenia Therapeutics Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
